Why the study?
Inconsistent therapeutic outcomes and limited understanding of mechanisms hinder the clinical translation of thyroid hormone administration following myocardial infarction.
Does acute triiodothyronine administration improve long-term LV function and reduce remodeling in a mouse model of myocardial infarction?
Does acute triiodothyronine administration improve long-term LV function and reduce remodeling in a mouse model of myocardial infarction?
Acute T3 administration following myocardial infarction in a mouse model improves long-term LV function and reduces remodeling by limiting apoptosis and preserving mitochondrial integrity.
Acute post-MI T3 may limit remodeling preclinically; leaves open clinical translation pending randomized trials.
Myocardial infarction (MI) is a leading cause of heart failure, with thyroid hormone (TH) signaling playing a key role in heart function and postinfarct recovery. Despite evidence of TH administration's safety in cardiac patients, inconsistent therapeutic outcomes and limited understanding of its mechanisms hinder clinical translation. This study aims to investigate the long-term effect of acute triiodothyronine (T3) administration following MI and to elucidate the mechanisms of its cardioprotective actions. To this end, two doses (40 μg/kg) of T3 were administered immediately after injury and 24 h later in a cryoinjury mouse model of left ventricle (LV) infarction. Remarkably T3 administration significantly reduced scar expansion. Echocardiographic analysis conducted 28 days post-injury revealed that T3 administration improved LV remodeling and prevented LV hypertrophy. At molecular level, T3 administration strongly reduced apoptosis in the peri-infarcted area, without inducing cardiac cell proliferation. Furthermore, T3 prevented the accumulation of long-chain acylcarnitines and the subsequent mitochondrial damage. These findings demonstrate that acute T3 treatment following MI improves long-term LV function and reduces LV remodeling by limiting apoptosis in the peri-infarct region and by preserving mitochondrial function and structural integrity.
No takes yet. Share an insight, caveat, or question.
Cerullo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: